🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yi Yang

Peking University

ORCID: 0000-0002-4200-745X

Also affiliated with Yale University, Second Affiliated Hospital of Guangzhou Medical University, Third Affiliated Hospital of Guangzhou Medical University, Center for Excellence in Molecular Cell Science, Peking University First Hospital, University of Chinese Academy of Sciences, Anshan Hospital, Massachusetts Institute of Technology, Guangzhou Medical University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer”.

Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.028
N/A
0.879DataRank · unranked
31 citations

Cem Demirkiran, Tobias M.P. Hartwich, Stefania Bellone, Diego Manavella, Levent Mutlu +10 more

Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.05.005
N/A
0DataRank · unranked
25 citations

Paola Manara, Diego Manavella, Stefania Bellone, Tobias M.P. Hartwich, Justin Harold +17 more

Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.04.010
N/A
0DataRank · unranked
9 citations

Michelle Greenman, Stefania Bellone, Blair McNamara, Tobias M.P. Hartwich, Diego Manavella +10 more

SORL1-Mediated EGFR and FGFR4 Regulation Enhances Chemoresistance in Ovarian Cancer

Cancers(2025)10.3390/cancers17020244
N/A
0DataRank · unranked
5 citations

Fangfang Bi, Zhiping Ge, Miranda Mansolf, Tobias M.P. Hartwich, Viktoriia Kolesnyk +8 more